Business in Brief: Children’s Savings Program Signed Into Law

Impax to buy portfolio of generic drugs from Teva, Allergan; Opko shares climb after FDA approves kidney-disease treatment; Tel Aviv shares turn lower at end of session.

comments Print
Children’s savings program signed into law